[HTML][HTML] When less is more: reevaluating the role of intensive chemotherapy for older adults with acute myeloid leukemia in the modern era

NJ Short, H Kantarjian - Journal of Clinical Oncology, 2021 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is predominantly a disease of older age, with a median age
of 68 years at diagnosis. 1 Older and unfit adults with AML (herein defined as age $60 …

[引用][C] When less is more: Reevaluating the role of intensive chemotherapy for older adults with acute myeloid leukemia in the modern era

NJ Short, H Kantarjian - Journal of Clinical Oncology, 2021 - mdanderson.elsevierpure.com
When less is more: Reevaluating the role of intensive chemotherapy for older adults with acute
myeloid leukemia in the modern era — MD Anderson Cancer Center Skip to main navigation …

When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era.

NJ Short, H Kantarjian - Journal of Clinical Oncology: Official Journal …, 2021 - europepmc.org
Acute myeloid leukemia (AML) is predominantly a disease of older age, with a median age
of 68 years at diagnosis. 1 Older and unfit adults with AML (herein defined as age $60 …

[引用][C] When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era

NJ Short, H Kantarjian - Journal of Clinical Oncology, 2021 - ascopubs.org
Acute myeloid leukemia (AML) is predominantly a disease of older age, with a median age
of 68 years at diagnosis. 1 Older and unfit adults with AML (herein defined as age $60 …

[引用][C] When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era

NJ Short, H Kantarjian - … journal of the American Society of …, 2021 - pubmed.ncbi.nlm.nih.gov